Compare Cronos Group Inc (CRON) vs Workday Inc (WDAY) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Cronos Group Inc vs Workday Inc — how do they compare? Cronos Group Inc trades at $3.23 (market cap $1.18B), while Workday Inc trades at $188.6 (market cap $45.26B). The key difference: Workday Inc is far larger — about 38.4× Cronos Group Inc's market cap, and Cronos Group Inc is trading nearer its 52-week high, Workday Inc nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold Cronos Group Inc for 22 Days and Workday Inc for 38 Days on average.
| CRON | WDAY | |
|---|---|---|
Market Cap | $1.18B | $45.26B |
Volume | 968,037 | 2,342,190 |
Sector | Health | Technology |
52-Week High | $3.55 | $245.67 |
52-Week Low | $2.30 | $112.55 |
Typical Hold Time | 22 Days | 38 Days |
Enterprise Value | $387.62M | $45.63B |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
CRON trades at $3.24, down 1.37% on the day, with a bearish technical signal and neutral oscillators. The company reported a net loss of $9.45M in 2025 despite revenue growth to $146.59M, but recent quarters show earnings beats. Analyst sentiment is mixed with 20% buy, 60% hold, and 20% sell ratings. Recent news highlights investor day events and international expansion efforts.
The outlook is cautious; profitability improvements and cash flow generation are key catalysts, but high valuation multiples and negative net cash flow pose risks. Regulatory developments in cannabis markets and execution on growth targets will be critical for stock performance.
Workday (WDAY) trades at $184.26, down 1.23% on the day, amid a broader tech selloff. The stock shows bearish technical signals with support at $182 and resistance at $187. Fundamentally, WDAY reported strong Q2 2026 EPS of $2.75, beating estimates, with revenue growth projected to reach $10.2B in 2026. Recent news includes strategic layoffs, AI product launches, and expansion in the UAE, highlighting its focus on enterprise AI solutions.
WDAY's outlook is supported by robust AI-driven revenue growth and a 50.6% analyst buy rating, with a consensus price target of $202.92 offering ~10% upside. Risks include integration costs from restructuring, competitive pressures in HR/finance software, and market volatility. The stock remains a compelling growth play if execution on AI monetization continues.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
No sentiment data available yet.
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Cronos Group Inc
Cronos Group, headquartered in Toronto, Canada cultivates and sells medicinal and recreational cannabis through its medicinal brand, Peace Naturals, and its two recreational brands, Cove and Spinach. Although it primarily operates in Canada, Cronos exports medical cannabis to Poland and Germany. In addition, it has entered joint ventures in Israel, Colombia, and Australia to drive further international cultivation and distribution growth. In the U.S. the company directly sells hemp-derived CBD and has an option to acquire 10.5% of U.S. multistate operator PharmaCann.
Read more on CRON →About Workday Inc
Workday is a software company that offers human capital management, or HCM, financial management, and business planning solutions. Known for being a cloud-only software provider, Workday is headquartered in Pleasanton, California. Founded in 2005, Workday now employs over 12,000 employees.
Read more on WDAY →
